Tenet Healthcare CorporationTHC

Gross margin stands at a robust 80.7%, which is typical for healthcare services where the cost structure is dominated by operating expenses rather than cost of goods sold, while net margin of 10.1% reflects a healthy conversion of revenue to bottom-line profit. The balance sheet is stretched, with a debt/equity ratio of 3.12x indicating significant leverage, though the current ratio of 1.76x provides adequate short-term liquidity coverage. Free cash flow generation is strong at $3.04B, translating to an attractive FCF yield of 14.2%, which gives the company meaningful capacity to service its debt obligations and fund reinvestment. The combination of high leverage and strong cash generation creates a picture of a company that is operationally efficient but financially constrained, with less flexibility than its cash flow alone might suggest.

DEBT — Debt/equity of 3.12x is highly elevated and significantly limits financial flexibility, though the current ratio of 1.76x provides adequate near-term liquidity. INSIDER SELLING — 9 insider sells versus 0 buys over the last 90 days represents a clear pattern of insiders reducing their positions, which often signals caution about near-term prospects. VALUATION DIVERGENCE — The Python DCF estimate of $670.9 per share diverges substantially from the current price of $265.05, creating uncertainty about whether the market or the model is mispricing the stock. TECHNICALS — RSI, MACD, and moving average data unavailable for this period; momentum cannot be independently confirmed. LEVERAGE RISK — The combination of 3.12x debt/equity with a capital-intensive hospital business model means the company is exposed to interest rate fluctuations and refinancing risk.